Background/Objectives:
Donepezil (DPL) is available as the hydrochloride
salt (DPL-HCL) which is highly water-soluble, prompting leakage of the drug into water
phase during solid lipid nanoparticles (SLNs) preparation which leads to reduce the entrapment
efficiency as well as drug content. So, the drug was converted into its base form
i.e. donepezil base (DPL base). The main objective of the work was to study the physicochemical
characterization and identification of DPL base and to compare it with parent
DPL-HCL, to develop a High-Performance Liquid Chromatography (HPLC) method for
the detection of DPL base in SLNs. The develop method was used for the determination
of shelf life of drug in SLNs.
Methods:
DPL-HCL was converted into DPL base simply by alkalization of DPL- HCL
with NaOH and then extracted into dichloromethane (DCM) followed by drying to obtain
DPL base. The HPLC method was developed and validated to quantify the DPL base for
the determination of its shelf life in SLNs. The drug content in the developed SLNs was
determined by extracting the DPL base using methanol as a solvent. The method was validated
for linearity, precision, accuracy, reproducibility, limit of detection (LOD) and
limit of quantification (LOQ).
Results:
DPL-HCL was successfully converted into DPL base with a yield value of
88.61%. The optimized mobile phase was comprised of 0.02 M phosphate buffer (pH
7.4), methanol and Acetonitrile (ACN) (40:50:10 v/v/v). The pH of mobile phase was adjusted
with o-phosphoric acid. The linearity range of the developed method was found to
be 0.5-80 µg/mL with LOD and LOQ value 0.086 and 0.263 µg/ml respectively. The
shelf life of the DPL base in SLNs was found to be 2.29 years.
Conclusion:
The HPLC method for donepezil base was successfully developed and validated.
RSD values for validated parameters were < 2, indicating the authenticity of the
developed method. The method was successfully used for the determination of shelf life
of the drug in SLNs.
Development and Validation of a RP-HPLC Method for Simultaneous Estimation of Antitubercular Drugs in Solid Lipid Nanoparticles